ZA200401757B - Crystals of hydroxynorephedrine derivate. - Google Patents

Crystals of hydroxynorephedrine derivate. Download PDF

Info

Publication number
ZA200401757B
ZA200401757B ZA200401757A ZA200401757A ZA200401757B ZA 200401757 B ZA200401757 B ZA 200401757B ZA 200401757 A ZA200401757 A ZA 200401757A ZA 200401757 A ZA200401757 A ZA 200401757A ZA 200401757 B ZA200401757 B ZA 200401757B
Authority
ZA
South Africa
Prior art keywords
compound
crystals
urinary incontinence
ethyl
ray powder
Prior art date
Application number
ZA200401757A
Other languages
English (en)
Inventor
Hidetoshi Isawa
Yukihiko Hotei
Kiyoshi Kasai
Junichi Sonehara
Satoshi Akahane
Hiromu Harada
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of ZA200401757B publication Critical patent/ZA200401757B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA200401757A 2001-09-13 2004-03-03 Crystals of hydroxynorephedrine derivate. ZA200401757B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001277345 2001-09-13

Publications (1)

Publication Number Publication Date
ZA200401757B true ZA200401757B (en) 2005-03-03

Family

ID=19101883

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200401757A ZA200401757B (en) 2001-09-13 2004-03-03 Crystals of hydroxynorephedrine derivate.

Country Status (28)

Country Link
US (1) US7208520B2 (ko)
EP (1) EP1426355B1 (ko)
JP (1) JP4157036B2 (ko)
KR (2) KR100874952B1 (ko)
CN (1) CN1275936C (ko)
AT (1) ATE411276T1 (ko)
AU (1) AU2002330453B2 (ko)
BR (1) BR0212494A (ko)
CA (1) CA2458544C (ko)
CO (1) CO5560555A2 (ko)
CY (1) CY1109409T1 (ko)
DE (1) DE60229404D1 (ko)
DK (1) DK1426355T3 (ko)
EA (1) EA006022B1 (ko)
EC (1) ECSP045017A (ko)
ES (1) ES2314092T3 (ko)
HR (1) HRP20040250A2 (ko)
HU (1) HUP0401694A3 (ko)
IL (2) IL160681A0 (ko)
MX (1) MXPA04002449A (ko)
NO (1) NO328252B1 (ko)
NZ (1) NZ531602A (ko)
PL (1) PL206246B1 (ko)
PT (1) PT1426355E (ko)
SI (1) SI1426355T1 (ko)
UA (1) UA77000C2 (ko)
WO (1) WO2003024916A1 (ko)
ZA (1) ZA200401757B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE602004015272D1 (de) * 2003-05-05 2008-09-04 Kissei Pharmaceutical Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blase
DE10351271A1 (de) * 2003-10-31 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung zur Behandlung der Stressinkontinenz und/oder Mischinkontinenz
AU2004285289A1 (en) * 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Pharmaceutical composition, containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha-reductase inhibitor
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
JP4808613B2 (ja) * 2004-03-24 2011-11-02 キッセイ薬品工業株式会社 頻尿または尿失禁の予防または治療用医薬
WO2005092321A1 (ja) * 2004-03-24 2005-10-06 Kissei Pharmaceutical Co., Ltd. 頻尿または尿失禁の予防または治療用医薬組成物
DE602004007905T2 (de) * 2004-06-28 2008-05-08 Grünenthal GmbH Kristalline Formen von (-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochlorid
DE102004050952A1 (de) * 2004-10-18 2006-04-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung zur Behandlung von Beschwerden, die mit krankhaften Veränderungen oder Irritationen der Prostata verbunden sind
WO2006042679A1 (de) * 2004-10-18 2006-04-27 Boehringer Ingelheim International Gmbh Verwendung eines beta-3-agonisten zur behandlung von beschwerden der prostata und des unteren urogenitaltrakts
EP1809591A1 (en) 2004-10-26 2007-07-25 Kissei Pharmaceutical Co., Ltd. Synthesis of phenoxyacetic acid derivatives
TWI356699B (en) 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
CA2605298A1 (en) * 2005-04-26 2006-11-09 Kissei Pharmaceutical Co., Ltd. Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate
US7763654B2 (en) 2005-04-26 2010-07-27 Kissei Pharmaceutical Co., Ltd. Crystal polymorph of hydroxynorephedrin derivative hydrochloride
EP1769792A1 (de) 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
JP5451613B2 (ja) 2007-08-06 2014-03-26 アラーガン、インコーポレイテッド デスモプレシン薬物送達のための方法及びデバイス
NO3085381T3 (ko) 2008-05-21 2018-09-15
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY126489A (en) 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
JP4005729B2 (ja) 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形
JP4005731B2 (ja) 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体の結晶多形
JP4005730B2 (ja) 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形

Also Published As

Publication number Publication date
AU2002330453B2 (en) 2008-04-17
IL160681A (en) 2010-06-16
EP1426355A1 (en) 2004-06-09
KR20040044881A (ko) 2004-05-31
CN1275936C (zh) 2006-09-20
DK1426355T3 (da) 2009-02-23
SI1426355T1 (sl) 2009-02-28
UA77000C2 (en) 2006-10-16
ATE411276T1 (de) 2008-10-15
NZ531602A (en) 2006-01-27
IL160681A0 (en) 2004-08-31
EP1426355B1 (en) 2008-10-15
EA200400311A1 (ru) 2004-08-26
PT1426355E (pt) 2008-11-03
NO20041060L (no) 2004-06-11
JPWO2003024916A1 (ja) 2004-12-24
PL206246B1 (pl) 2010-07-30
HK1070051A1 (en) 2005-06-10
EP1426355A4 (en) 2006-03-29
CA2458544C (en) 2010-08-17
ECSP045017A (es) 2004-09-27
EA006022B1 (ru) 2005-08-25
CN1553890A (zh) 2004-12-08
JP4157036B2 (ja) 2008-09-24
HRP20040250A2 (en) 2005-02-28
US7208520B2 (en) 2007-04-24
CY1109409T1 (el) 2014-07-02
CO5560555A2 (es) 2005-09-30
ES2314092T3 (es) 2009-03-16
US20040242686A1 (en) 2004-12-02
HUP0401694A3 (en) 2008-03-28
KR20080098691A (ko) 2008-11-11
BR0212494A (pt) 2004-08-24
DE60229404D1 (de) 2008-11-27
WO2003024916A1 (en) 2003-03-27
CA2458544A1 (en) 2003-03-27
PL367874A1 (en) 2005-03-07
MXPA04002449A (es) 2004-07-23
NO328252B1 (no) 2010-01-18
KR100874952B1 (ko) 2008-12-19
HUP0401694A2 (hu) 2004-11-29

Similar Documents

Publication Publication Date Title
CA2458544C (en) Crystals of hydroxynorephedrine derivative
US9029420B2 (en) Agomelatine and pharmaceutical compositions thereof
JP5319920B2 (ja) ナトリウムおよび／またはカルシウムチャンネル選択的調節因子として活性のある医薬の製造のための（ハロベンジルオキシ）ベンジルアミノ−プロパンアミドの使用
JP2008512405A5 (ko)
US7030164B2 (en) Crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
US7763654B2 (en) Crystal polymorph of hydroxynorephedrin derivative hydrochloride
US20040092498A1 (en) Substituted glycine derivatives for use as medicaments
HK1070051B (en) Crystals of hydroxynorephedrine derivative
WO2004016583A1 (en) Substituted glycine derivatives for use as medicaments
US8003694B2 (en) Crystal of hydroxynorephedrin derivative hydrochloride ¼ hydrate
JP2007314534A (ja) 医薬および動物薬として適切な塩